NextBio's Scientific Advisory Board Brings Together Thought-leaders from Systems Biology, Genomics and Bioinformatics.CUPERTINO, Calif. -- NextBio[TM], whose innovative knowledge-based discovery platform introduces a new paradigm New Paradigm In the investing world, a totally new way of doing things that has a huge effect on business. Notes: The word "paradigm" is defined as a pattern or model, and it has been used in science to refer to a theoretical framework. in the management and interpretation of biological and clinical information, today announced the founding members of its Scientific Advisory Board (SAB): Dr. Leroy Hood Leroy Hood is an American biologist. He won the 2003 Lemelson-MIT Prize for inventing "four instruments that have unlocked much of the mystery of human biology" by helping decode the genome. , Dr. Ronald Davis, Dr. Mostafa Ronaghi Mostafa Ronaghi is a molecular biologist, specializing in DNA sequencing methodology . He earned his Ph.D. from the Royal Institute of Technology in Sweden. He is currently a principal investigator and Senior Research Associate at the Stanford Genome Technology Center at Stanford , Dr. Keith Joho, Dr. Nick Tsinoremas and Dr. Saeed Tavazoie. The SAB, which comprises a broad base of scientific experts from academic and industry research settings, will offer guidance to NextBio management in ensuring the biological and clinical relevance of future product development. Leroy Hood, M.D, Ph.D.: "One of the challenges of the new systems biology Systems biology, a field of study in the biosciences, focuses on the systematic study of complex interactions in biological systems. Particularly from 2000 onwards, the term is used widely in the biosciences, and in a variety of contexts. paradigm is how to enable scientists to easily sift through vast quantities of large-scale information that cannot be easily captured in published literature and, at the same time, organize and integrate different types of data in ways that are conducive to computational analysis and modeling. NextBio has made striking progress toward that objective." Dr. Hood is President and co-founder of the Institute for Systems Biology The Institute for Systems Biology (ISB) is a non-profit research institution, located in Seattle, Washington, United States. Leroy Hood co-founded the Institute with Alan Aderem and Ruedi Aebersold in 2000. in Seattle, Washington  This page is protected from moves until disputes have been resolved on the .The reason for its protection is listed on the protection policy page. . He has been at the forefront of scientific discovery and technological research for more than 35 years. Dr. Hood has published more than 600 peer-reviewed papers, received 12 patents, co-founded nearly a dozen companies and was awarded the 2002 Kyoto Prize The Kyoto Prize (京都賞) has been awarded annually since 1984 by the Inamori Foundation, founded by Kazuo Inamori (fortune from ceramics). The prizes are the Japanese equivalent of the Nobel Prize, as they recognize outstanding works in the fields of philosophy, in Advanced Technology for his outstanding contributions to biotechnology and medical technology. Ronald Davis, Ph.D.: "What NextBio is doing for biological information is analogous to what happened when we went from northern blots to microarrays." Dr. Davis is the Director of the Stanford Genome Technology Center and Professor of Biochemistry and Genetics at the Stanford University School of Medicine Stanford University School of Medicine is affiliated with Stanford University and is located at Stanford University Medical Center in Stanford, California, adjacent to Palo Alto and Menlo Park. . He is a world-renowned researcher in the areas of genomics and high-throughput biochemical techniques. He pioneered many of the early techniques using recombinant DNA recombinant DNA n. Genetically engineered DNA prepared by transplanting or splicing one or more segments of DNA into the chromosomes of an organism from a different species. Such DNA becomes part of the host's genetic makeup and is replicated. and helped conceive of novel methods for genetic linkage analysis. Professor Davis has also been involved in the spin-off of multiple start-up companies in the area of genomics from his laboratory at Stanford. Mostafa Ronaghi, Ph.D.: "The systematic collection of information provides the backbone of biology. Any one study is just a piece of the puzzle in an ocean of pieces. NextBio connects the pieces of the puzzle, revealing new insights into biological systems." Dr. Ronaghi is co-founder of NextBio and an experienced entrepreneur. He co-founded Pyrosequencing in 1997 (renamed to Biotage in 2003) and ParAllele BioScience in 2001 (sold to Affymetrix). He is currently a principal investigator at Stanford University focusing on developing novel tools for molecular diagnostics. Dr. Ronaghi holds more than 20 pending and issued patents and has written more than 50 peer-reviewed publications in journals and books. Keith Joho, Ph.D.: "The research community has been looking for Looking for In the context of general equities, this describing a buy interest in which a dealer is asked to offer stock, often involving a capital commitment. Antithesis of in touch with. a solution like NextBio for the last ten years. It's going to have a huge impact on productivity." Dr. Joho is a leader in the bioinformatics community having held senior management positions in bioinformatics at Ingenuity Systems, SurroMed, Abgenix, Roche Bioscience and SUGEN. He has also served on the faculty of the Department of Biochemistry and Molecular Biology molecular biology, scientific study of the molecular basis of life processes, including cellular respiration, excretion, and reproduction. The term molecular biology was coined in 1938 by Warren Weaver, then director of the natural sciences program at the Rockefeller at the Louisiana State University Louisiana State University and Agricultural and Mechanical College, generally known as Louisiana State University or LSU, is a public, coeducational university located in Baton Rouge, Louisiana and the main campus of the Louisiana State University System. Medical Center. He is currently a consultant focusing on informatics challenges in biopharmaceutical research. Nick Tsinoremas, Ph.D.: "NextBio is liberating for bench scientists. It gives them an intuitive way to query across private and curated public data without having to be bioinformatics experts." Dr. Tsinoremas is a Senior Director of Informatics at Scripps Florida where he oversees data analysis systems ranging from statistical genetics and data mining to chemo-informatics and sequence-based analysis. Previously, Dr. Tsinoremas held senior positions in computational genomics and bioinformatics at Rosetta/Merck, DoubleTwist, Incyte Genomics and Progenitor pro·gen·i·tor n. 1. A direct ancestor. 2. An originator of a line of descent. progenitor ancestor, including parent. progenitor cell stem cells. . Dr. Tsinoremas' original research includes light-regulated gene expression and circadian rhythms. Saeed Tavazoie, Ph.D.: "NextBio's intuitive platform allows the biologist to navigate through the astronomical number of hypotheses that modern datasets make possible. This is the first step in turning mountains of data into new discoveries." Dr. Tavazoie is a professor in the Department of Molecular Biology and the Lewis-Sigler Institute for Integrative Genomics at Princeton University. He has done pioneering research in the areas of computational biology and functional genomics. Professor Tavazoie has broad cross-disciplinary expertise in biophysics biophysics, application of various methods and principles of physical science to the study of biological problems. In physiological biophysics physical mechanisms have been used to explain such biological processes as the transmission of nerve impulses, the muscle , molecular biology, genomics, computational biology, and medicine. His current research is aimed at developing new conceptual frameworks for extracting biological understanding from large experimental datasets. "NextBio's goal is to remove informatics barriers that have impeded biopharmaceutical research for years, and that goal is founded on a philosophy of innovation", said Saeid Akhtari, president, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. and co-founder of NextBio. "This is clearly a philosophy we share with each member of our Scientific Advisory Board. We are honored to be working with this distinguished group of scientists." Please visit http://www.nextbio.com for more information. About NextBio NextBio accelerates biological and clinical discovery by overcoming many of the challenges created by an overwhelming abundance of disparate, high-throughput experimental data. Founded in 2004 by a team of industry leaders, NextBio addresses a fundamental need within R&D organizations to effectively leverage vast quantities of internal and public information to advance research-critical discoveries. NextBio's knowledge-based discovery platform enables all researchers to tap into the power of information combined from different assays, platforms and research silos to draw new scientific and clinical insights. Its value in improving research efficiency and effectiveness has already been proven at some of the world's leading research organizations. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion